"Made-in-Shanghai" will Land in Osaka Showcasing Shanghai's Fashion Ecosystem in May

"Made-in-Shanghai" will Land in Osaka Showcasing Shanghai's Fashion Ecosystem in May

OSAKA, Japan, May 15, 2025 /PRNewswire/ -- As Chinese solar term "Grain Buds" kicks in, a summer fashion harvest is about to begin! "Made in Shanghai", Shanghai's major fashion exhibition & trade event will land in Umeda, Osaka's liveliest area...

FOR SALE BY EXPRESSION OF INTEREST: Freehold Non-Conserved Commercial Building at 562 Serangoon Road

FOR SALE BY EXPRESSION OF INTEREST: Freehold Non-Conserved Commercial Building at 562 Serangoon Road

SINGAPORE, May 15, 2025 /PRNewswire/ -- Brilliance Capital Pte. Ltd. is proud to present to the market an exceptionally rare opportunity to acquire a freehold commercial building with individual strata titles per floor at 562 Serangoon Road, a...

Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025

Taiwantrade.com Brings Taiwan's ICT Excellence to COMPUTEX 2025

TAIPEI, May 13, 2025 /PRNewswire/ -- Taiwantrade.com, Taiwan's leading B2B e-commerce platform, is excited to showcase the best of Taiwan's ICT industry at COMPUTEX 2025, taking place May 20–23 at Taipei Nangang Exhibition Center Hall 2 (TaiNEX 2)....

Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congress

Abbisko Therapeutics to Present Updated Results from the Phase 2 Study of Irpagratinib in Combination with Atezolizumab for the Treatment of Advanced Hepatocellular Carcinoma at the 2025 ESMO GI Congress

SHANGHAI, May 13, 2025 /PRNewswire/ -- Abbisko Therapeutics Co., Ltd. (02256.HK) today announced that updated results from the phase 2 study of irpagratinib (ABSK011) in combination with atezolizumab for the treatment of advanced hepatocellular...

Storage Meets AI: Longsys to Showcase Comprehensive Innovation at COMPUTEX 2025

Storage Meets AI: Longsys to Showcase Comprehensive Innovation at COMPUTEX 2025

SHENZHEN, China, May 12, 2025 /PRNewswire/ -- Longsys(301308.SZ), a branded semiconductor enterprise, will exhibit at COMPUTEX 2025 from May 20 to 23 at the Taipei Nangang Exhibition Center, under the theme "Storage Meets AI." As artificial...

Nick Offerman and Megan Mullally Bring Unscripted and Unfiltered Chaos to Vivid Sydney

Nick Offerman and Megan Mullally Bring Unscripted and Unfiltered Chaos to Vivid Sydney

SYDNEY, May 8, 2025 /PRNewswire/ -- Television icons Nick Offerman and Megan Mullally will appear on stage together for the first time in Australia at Vivid Sydney 2025, the Southern Hemisphere's largest arts and culture festival. Unscripted and...

Gamma Communications Recognized with Frost & Sullivan's 2024 European UCaaS Competitive Strategy Leadership Award

Gamma Communications Recognized with Frost & Sullivan's 2024 European UCaaS Competitive Strategy Leadership Award

The company has shown exceptional strategy execution, innovation, and customer-centric growth in a rapidly evolving market. SAN ANTONIO, Texas, May 6, 2025 /PRNewswire/ -- Frost & Sullivan is proud to present Gamma Communications with the 2024...

HVL Hotels: Redefining Luxury in the Heart of the Hunter Valley

HVL Hotels: Redefining Luxury in the Heart of the Hunter Valley

SYDNEY, April 30, 2025 /PRNewswire/ -- HVL Hotels in conjunction with Figure 8 capital is proud to present a visionary luxury hospitality project poised to redefine the Hunter Valley experience. This ultra-premium destination reimagines what a...

Avnet AI Tech Days Empower Singapore's AI Ambitions

Avnet AI Tech Days Empower Singapore's AI Ambitions

Event in Singapore to Showcase Latest AI Solutions and Expertise, Supporting National Growth Goals SINGAPORE, April 29, 2025 /PRNewswire/ -- Building on Singapore's growing leadership in artificial intelligence (AI), fueled by strategic initiatives...

Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

Juncell Therapeutics Announces Data on Feeder-free IL-2-Independent TIL Manufacturing Process at ASGCT Annual Meeting 2025

SHANGHAI, April 29, 2025 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech specializing in developing innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies for cancer, today...

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • menu
    menu